Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of Oxford COVID-19 vaccine

Next Previous
Search
Trial Profile

A clinical trial of Oxford COVID-19 vaccine

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AZD 1222 (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 12 Sep 2020 According to an AstraZeneca media release, the Company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume.
    • 12 Sep 2020 According to an AstraZeneca media release, AstraZeneca and the University of Oxford, as the trial sponsor, cannot disclose further medical information. All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards.
    • 12 Sep 2020 According to an AstraZeneca media release, clinical trials of AZD-1222 have been resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top